Patents by Inventor Todd A Thompson
Todd A Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11974667Abstract: The present invention relates to a modular storage system for barrels. The modular storage system includes a base rick module, an aisle rick module, and an end rick module, whereby a plurality of each module type may be assembled to construct a rickhouse.Type: GrantFiled: April 7, 2021Date of Patent: May 7, 2024Assignee: Koetter-Rax, LLCInventors: Robert J. Koetter, Jr., Kenneth E. Koetter, Gerald T. Koetter, Raymond Todd Magner, Brian S. Keith, Greg Schmidt, Anthony Ferrera, Mark Duane Cooke, Clark Gregory, Darr Scott Thompson, Adam Ray
-
Patent number: 11952833Abstract: Building systems including a frame with a horizontal member from which first and second vertical bars downwardly extend and a panel attached to the frame. The building systems include at least one of an integrated fastener cover that is moveable to a closed position that covers a portion of a fastener, a gusset assembly with a junction cover positioned at a corner junction between two adjacent portions of a panel, and hinge assemblies that reduce the sagging of a panel, such as a door.Type: GrantFiled: September 11, 2020Date of Patent: April 9, 2024Assignee: Larson Manufacturing Company of South Dakota, LLCInventors: Sara Wermers, Alan M. Dixon, Matthew Gingery, Kelly D. Nordgaard, Luke A. Thompson, Bryan P. Zacher, Jammey A. Rawden, Todd N. Stratmoen, Michael W. Kondratuk
-
Publication number: 20240074868Abstract: An example method is provided for maintaining stability to an injury defined by a separation of two bones (e.g., the tibia and fibula), the separation being an injured distance greater than a pre-injury distance between the two bones in a first human patient. The method may include delivering a first apparatus for approximation of the two bones in the first human patient comprising the injury, the first apparatus including a flexible segment disposed between a first anchor and a second anchor. The method may further include maintaining, by the first apparatus, a restored distance between the two bones in the first human patient after a repetitive dynamic loading, the restored distance approximately equal to the pre-injury distance.Type: ApplicationFiled: September 7, 2022Publication date: March 7, 2024Applicant: DePuy Synthes Products, Inc.Inventors: Firas SOULEIMAN, Ivan ZDERIC, Torsten PASTOR, Dominic GEHWEILER, Boyko GUEORGUIEV-RÜEGG, Michael SWORDS, Tim SCHEPERS, Matthew TOMLINSON, Charles HORRELL, Nicholas MOURLAS, Jon THOMPSON, Todd KENT, Jessica GALIE
-
Publication number: 20200342555Abstract: A system and method are disclosed that track a deliverable to a user. The system includes an identifier or tag secured to the deliverable, a computer system for interrogating the identifier, and a personal device in communication with the computer system, wherein the personal device is held by the user at the time the user is administered the deliverable to detect the unique identity associated with the identifier device and confirms delivery of the deliverable to the user. The method includes attaching an identifiable tag that produces a unique signature to the deliverable, interrogating the tag at about the time of delivery to the user, and confirming that the user has been administered the deliverable through detecting the identifiable tag.Type: ApplicationFiled: November 12, 2019Publication date: October 29, 2020Inventors: Todd THOMPSON, Lawrence ARNE, Fataneh OMIDVAR, Yashar BEHZADI, Robert DUCK, Lorenzo DICARLO, Gregory MOON
-
Patent number: 10529044Abstract: A system and method are disclosed that track a deliverable to a user. The system includes an identifier or tag secured to the deliverable, a computer system for interrogating the identifier, and a personal device in communication with the computer system, wherein the personal device is held by the user at the time the user is administered the deliverable to detect the unique identity associated with the identifier device and confirms delivery of the deliverable to the user. The method includes attaching an identifiable tag that produces a unique signature to the deliverable, interrogating the tag at about the time of delivery to the user, and confirming that the user has been administered the deliverable through detecting the identifiable tag.Type: GrantFiled: May 19, 2011Date of Patent: January 7, 2020Assignee: Proteus Digital Health, Inc.Inventors: Todd Thompson, Lawrence Arne, Fataneh Omidvar, Yashar Behzadi, Robert Duck, Lorenzo Dicarlo, Gregory Moon
-
Publication number: 20190191006Abstract: A method comprising receiving physiologic information at a social-networking system from a body-associated personal communicator is disclosed. A social-networking system configured to receive physiological information from a body-associated personal communicator and a body-associated personal communicator configured to receive physiologic information and communicate the physiologic information to a social-networking system also are disclosed.Type: ApplicationFiled: July 3, 2018Publication date: June 20, 2019Inventors: Andrew Thompson, Todd Thompson, Yashar Behzadi, Danielle Cojuangco Abraham, Robert Duck, Arna Ionescu, Ray Lee, Robin Suchan, William Turner, Veeraperumanallu Muralidharan, Erika Karplus, George Savage
-
Publication number: 20180330327Abstract: The present disclosure includes an app provisioned with a geo-fencing policy, and the geo-fencing policy initializes once within a pre-defined geographical area. If the device is within the defined area, the app starts tracking a mobile unit. The geographical area, such as a building construction site, restaurant, or company campus, is defined using longitude and latitude coordinates and a location accuracy value. Device location is obtained using location/GPS services on the device, private network, or cellular tower triangulation. The app uses the location meta data to build reports, such as productivity, and hours on site to be compared with hourly billing, and also allows for notifications once a certain individual is within the geographical area—thus allowing for gathering of individuals to be easier.Type: ApplicationFiled: May 11, 2018Publication date: November 15, 2018Inventors: Daniel Dominic Hertenstein, Josef Michael Hertenstein, Ronald Todd Thompson
-
Patent number: 10084880Abstract: A method comprising receiving physiologic information at a social-networking system from a body-associated personal communicator is disclosed. A social-networking system configured to receive physiological information from a body-associated personal communicator and a body-associated personal communicator configured to receive physiologic information and communicate the physiologic information to a social-networking system also are disclosed.Type: GrantFiled: November 4, 2014Date of Patent: September 25, 2018Assignee: PROTEUS DIGITAL HEALTH, INC.Inventors: Andrew Thompson, Todd Thompson, Yashar Behzadi, Danielle Cojuangco Abraham, Robert Duck, Arna Ionescu, Ray Lee, Robin Suchan, William Turner, Veeraperumanallu Muralidharan, Erika Karplus, George Savage
-
Patent number: 9597010Abstract: The system of the present invention includes an implantable device that can detect high and low frequency current signature. The implantable device can communicate with a communication device that includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, the communication device is activated.Type: GrantFiled: April 23, 2014Date of Patent: March 21, 2017Assignee: Proteus Digital Health, Inc.Inventors: Todd Thompson, Mark Zdeblick, Yashar Behzadi, Benedict Costello, Timothy Robertson, Hooman Hafezi, George Savage
-
Patent number: 9440942Abstract: Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer.Type: GrantFiled: July 10, 2014Date of Patent: September 13, 2016Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATIONInventors: Todd A. Thompson, George Wilding
-
Patent number: 9439566Abstract: A re-wearable wireless device includes a reusable component to be secured to a disposable component. The reusable component includes a sensor interface to receive signals from an electrode secured to a living subject and monitors physiological and physical parameters associated with the living subject and a cellular wireless communication circuit. An adhesive base the device includes a first adhesive layer and a second adhesive layer partially covering the first adhesive layer around a perimeter thereof, where the first and second adhesive layers include different adhesives. A method of establishing a link between two wireless devices is also disclosed, where a first wireless device with an insignia representing a communication channel address identification is provided. An image of the insignia is captured with a mobile telephone computing device comprising an image sensor. The captured image is processed to extract the communication channel address identification represented by the insignia.Type: GrantFiled: March 15, 2013Date of Patent: September 13, 2016Assignee: Proteus Digital Health, Inc.Inventors: Lawrence Arne, Todd Thompson, Timothy Robertson, Robert Azevedo
-
Patent number: 9439599Abstract: A body associated device comprises a housing, an adhesive layer configured to be applied to a body of a living subject, and at least one standoff located between the housing and the adhesive layer. An electronic module may be located within the housing of the body associated device. A personal communication system comprises a body associated device including an electronic module and further comprises a feedback portion coupled to the housing and to the electronic module. The feedback portion is configured to communicate information between the living subject and the body associated device. An external local node is operative to provide at least one of transmit communications to and receive communications from the body associated device.Type: GrantFiled: March 8, 2012Date of Patent: September 13, 2016Assignee: Proteus Digital Health, Inc.Inventors: Todd Thompson, Olivier Colliou, Robert Duck, Yashar Behzadi
-
Patent number: 9326974Abstract: A method of treatment and/or prevention of cancer comprises administering agents which cause increased intracellular granularity in cancer cells, at least in an amount sufficient to inhibit proliferation of such cells and preferably in an amount sufficient to lead to cancer cell death. The method is particularly directed to refractory cancer, particularly hormone refractory prostate cancer. The agents identified cause increased intracellular granularity in the cancer cells, and also convert adherent cancer cells to non-adherent cancer cells, leading to cancer cell death. Using the present invention, cancer cells undergo increased intracellular granularity at relatively low agent concentrations, while also inhibiting cell proliferation. Increased concentrations lead to conversion of adherent cancer cells to non-adherent cancer cells, then to cell death.Type: GrantFiled: August 1, 2014Date of Patent: May 3, 2016Assignee: STC.UNMInventors: Todd A. Thompson, Debra Mackenzie, Tudor I. Oprea, Larry A. Sklar, Bruce S. Edwards, Mark Haynes
-
Publication number: 20150149375Abstract: In one aspect, this disclosure provides a crowd endorsement social engine for endorsing an athlete. In various aspects crowd endorsement of athletes includes income and training support for semi-pro, amateur, Olympic athletes, sponsorship from family, friends, fans, and social community. In one aspect, individual athlete campaigns highlight goals, progress and achievement. In another aspect, athletes produce blog style updates on progress, physiologic tweets during competition in the form of broadcasting messages. In another aspect, sponsors create emotional attachment to their athlete and his/her success and provide encouragement. In another aspect, fans that attend events provide live updates to athletes' pages. In another aspect, community growth is based on athlete adoption and sponsor base.Type: ApplicationFiled: November 21, 2014Publication date: May 28, 2015Inventors: Andrew Thompson, Todd Thompson
-
Publication number: 20150127737Abstract: A method comprising receiving physiologic information at a social-networking system from a body-associated personal communicator is disclosed. A social-networking system configured to receive physiological information from a body-associated personal communicator and a body-associated personal communicator configured to receive physiologic information and communicate the physiologic information to a social-networking system also are disclosed.Type: ApplicationFiled: November 4, 2014Publication date: May 7, 2015Inventors: Andrew Thompson, Todd Thompson, Yashar Behzadi, Danielle Cojuangco, Robert Duck, Arna Ionescu, Ray Lee, Robin Suchan, William Turner, Veeraperumanallu Muralidharan, Erika Karplus, George Savage
-
Publication number: 20150080677Abstract: The system of the present invention includes an implantable device that can detect high and low frequency current signature. The implantable device can communicate with a communication device that includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, the communication device is activated.Type: ApplicationFiled: April 23, 2014Publication date: March 19, 2015Inventors: Todd Thompson, Mark Zdeblick, Yashar Behzadi, Benedict Costello, Timothy Robertson, HOOMAN HAFEZI, George Savage
-
Publication number: 20140343347Abstract: A method of treatment and/or prevention of cancer comprises administering agents which cause increased intracellular granularity in cancer cells, at least in an amount sufficient to inhibit proliferation of such cells and preferably in an amount sufficient to lead to cancer cell death. The method is particularly directed to refractory cancer, particularly hormone refractory prostate cancer. The agents identified cause increased intracellular granularity in the cancer cells, and also convert adherent cancer cells to non-adherent cancer cells, leading to cancer cell death. Using the present invention, cancer cells undergo increased intracellular granularity at relatively low agent concentrations, while also inhibiting cell proliferation. Increased concentrations lead to conversion of adherent cancer cells to non-adherent cancer cells, then to cell death.Type: ApplicationFiled: August 1, 2014Publication date: November 20, 2014Inventors: Todd A. Thompson, Debra Mackenzie, Tudor I. Oprea, Larry A. Sklar, Bruce S. Edwards, Mark Haynes
-
Publication number: 20140323560Abstract: Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer.Type: ApplicationFiled: July 10, 2014Publication date: October 30, 2014Inventors: Todd A. Thompson, George Wilding
-
Patent number: 8835506Abstract: A method of treatment and/or prevention of cancer comprises administering agents which cause increased intracellular granularity in cancer cells, at least in an amount sufficient to inhibit proliferation of such cells and preferably in an amount sufficient to lead to cancer cell death. The method is particularly directed to refractory cancer, particularly hormone refractory prostate cancer. The agents identified cause increased intracellular granularity in the cancer cells, and also convert adherent cancer cells to non-adherent cancer cells, leading to cancer cell death. Using the present invention, cancer cells undergo increased intracellular granularity at relatively low agent concentrations, while also inhibiting cell proliferation. Increased concentrations lead to conversion of adherent cancer cells to non-adherent cancer cells, then to cell death.Type: GrantFiled: June 5, 2009Date of Patent: September 16, 2014Assignee: STC.UNMInventors: Todd A. Thompson, Debra Mackenzie, Tudor I. Oprea, Larry A. Sklar, Bruce S. Edwards, Mark Haynes
-
Patent number: 8809387Abstract: Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer.Type: GrantFiled: August 14, 2013Date of Patent: August 19, 2014Assignee: Wisconsin Alumni Research FoundationInventors: Todd A. Thompson, George Wilding